LithuaniaBIO

What LithuaniaBIO does

LithuaniaBIO is a non-profit industry association founded in 2003 and headquartered in Vilnius, Lithuania, serving as the central representative body for the country's life sciences and biotechnology sector. It counts approximately 70 members spanning companies, academic institutions, and healthcare organizations, and its core activities include sector advocacy with government bodies, organization of networking and educational events, and participation in EU-funded collaborative projects such as BIO-INSPIRE, BIO-RED, and DIVERSE_GENE_WATCH. Notable member companies include CasZyme (CRISPR tools), Biomatter (generative AI for protein design), Atrandi Biosciences (microfluidics; $25M Series A), and VUGENE (cell and gene therapy), reflecting a member base oriented toward platform technologies and product-stage companies.

The association operates a hybrid revenue model combining membership fees, EU-funded project grants, and event-related income, and it maintains a broad partnership network that includes ECHAlliance, Sorainen, Invest Lithuania, the Research Council of Lithuania, BIC, CBE JU, RockIT, and BioConnect (Baltic Biotech Hub). Governance is provided by a board led by President Tomas Andrejauskas and Vice President Agnė Vaitkevičienė, with board member Gražina Mykolaitytė also serving as CEO of member company VUGENE. A new Executive Director, Simona Šimulytė, was appointed in January 2026, coinciding with an expanded international programming agenda.

LithuaniaBIO's strategic context is shaped by Lithuania's national life sciences strategy, which targets raising the sector's contribution to GDP from 2.7% to 5% by 2030. The sector itself is reported to be growing 19-30% annually with 170% growth over three years and 90% of products exported to over 100 countries. Against this backdrop, the association has been actively broadening its international engagement, including participation in Swiss Biotech Day 2026 and co-organization of the EU Biotech Playbook lecture series with Sorainen, positioning itself as a coordinator between Lithuanian members and pan-European policy, funding, and commercialization frameworks.

Name

LithuaniaBIO

Legal name

Lithuanian Biotechnology Association (LithuaniaBIO)

Website

https://lithuaniabio.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

LithuaniaBIO is a Vilnius-based non-profit industry association founded in 2003 representing approximately 70 Lithuanian life sciences members across industry, academia, and healthcare. It advocates for the sector, organizes events, and participates in EU-funded collaborative projects.

Ownership category

akta.pro rank

Product category

Life Sciences Industry Association

NAICS

Business Associations (813910)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Circular Economy & Resource Efficiency (BPADALAM), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Biotechnology association
• Life sciences networking
• Biotech industry advocacy
• Bioeconomy development
• Health technology ecosystem

Headquarters

HQ city

Vilnius

HQ country

Lithuania

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership fees: Association generates revenue through membership fees from companies, research institutions, and healthcare organizations in the life sciences and biotechnology sector

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

LithuaniaBIO is a non-governmental industry association that connects Lithuanian life sciences and biotechnology institutions — including companies, research and academic institutions, and healthcare organizations — through membership services, networking events, educational programs, and coordination of EU-funded research projects. It represents the sector's interests nationally and internationally, facilitates innovation application, technology transfer, and commercialization, and acts as the Lithuanian Health Technology Ecosystem within ECHAlliance.

Product overview

LithuaniaBIO is a non-governmental industry association representing companies, research institutions, study institutions, and healthcare institutions in the fields of diagnostics, health technologies, and biotechnology in Lithuania. The association does not offer commercial software products but instead provides membership services, organizes industry events, facilitates networking, and coordinates European research projects (such as BIO-INSPIRE, BIO-RED, and DIVERSE_GENE_WATCH). Priority activity areas include Life Sciences (bioeconomy), Health technologies (medical devices), and Bioeconomy. The association also hosts educational initiatives such as the EU Biotech Playbook lecture series for regulatory and legal guidance to biotech companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Association Membership Membership program that provides Lithuanian life sciences companies, research institutions, and healthcare organizations with industry representation, networking, advocacy, technology transfer support, and access to EU-funded projects and international conferences. Currently has approximately 70 members.

Quantifiable outcome

• 19-30% annual sector growth, one of the most rapid in EU
• +2 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• SorainencoreStrategic or Co-development Partner · 18 March 2026Sorainen law firm partners with LithuaniaBIO to deliver the EU Biotech Playbook lecture series, providing legal and regulatory guidance to biotech companies navigating EU regulatory challenges. Partner Lise-Lotte Lääne leads the firm's Life Sciences & Healthcare sector group.
• ECHAlliancecoreStrategic or Co-development PartnerLithuaniaBIO joined ECHAlliance as the Lithuanian Health Technology Ecosystem, connecting 78 countries and 4.4 billion people with 700+ member organizations and 16,500+ experts through international network of ecosystems.
• Bio-based Industries Consortium (BIC)minorStrategic or Co-development PartnerLBTA joined BIC to actively participate in development of Lithuanian bioindustry and bioeconomy. BIC is Brussels-based European Bioindustry Consortium acting as private partner in public-private sector with EU's Bio-based Industries Joint Undertaking (BBI JU).
• Circular Bio-based Europe Joint Undertaking (CBE JU)coreStrategic or Co-development PartnerLithuaniaBIO participates in BIO-INSPIRE project together with CBE JU, engaging regional bioeconomy clusters for matchmaking and facilitating new partnerships in bioeconomy innovations.
• Research Council of LithuaniacoreStrategic or Co-development PartnerCo-organizer of Life Sciences, Biotechnology, and Bioeconomy Day events, supporting innovation ecosystem development in Lithuania.
• Invest LithuaniaminorStrategic or Co-development PartnerPartnered for Lithuanian delegation participation in Swiss Biotech Day 2026 and other international events.
• RockITminorImplementation/ SI/ Consulting PartnerVenue host for EU Biotech Playbook lecture series events in Vilnius.
• BioConnect (Baltic Biotech Hub)coreStrategic or Co-development PartnerLithuania, Latvia, and Estonia joining forces through Baltic Biotech Action Plan to create integrated regional biotechnology ecosystem. Lithuania contributes strengths in R&D, gene editing, and protein synthesis.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• One Nucleus: UK-based life sciences and healthcare membership organization. Comparable in providing networking, partnering events, and member services to biotech and medtech companies, with similar association business model.
• bio.be / essenscia: Belgian biotech and life sciences federation, part of essenscia. Directly comparable as a national biotech industry association representing companies and research institutions.
• BIO Deutschland: Germany's national biotechnology industry association. Directly comparable to LithuaniaBIO as a national industry association representing biotech, medtech, and life sciences companies, though operating at significantly larger scale with hundreds of members.
• France Biotech: French national association of life sciences and biotech companies and their partners. Closely parallel to LithuaniaBIO in mission (advocacy, networking, ecosystem development for biotech entrepreneurs and SMEs).
• Swiss Biotech Association: Swiss national biotechnology industry association, host of Swiss Biotech Day (where LithuaniaBIO has actively brought delegations). Direct functional peer in representing a national biotech ecosystem internationally.
• SwedenBIO: Swedish life sciences industry association. Comparable as a Nordic-Baltic region industry association focused on life sciences, with similar scale, mission, and member composition (companies, academia, healthcare).
• BioIndustry Association (BIA, UK): UK trade association for the life sciences and biotech sector. Functions as a direct national-cluster peer, providing advocacy, networking, and policy representation for UK life sciences companies and researchers.

Others

• ECHAlliance: European Connected Health Alliance, a global network of health technology ecosystems. LithuaniaBIO is already a member as the Lithuanian Health Technology Ecosystem; relevant peer in the ecosystem-network business model rather than direct competition.

Broad incumbents

• EuropaBio: Pan-European biotechnology industry association. A broader incumbent operating at the EU level rather than nationally; relevant comparator for LithuaniaBIO's EU-level advocacy and project work.

Regional players

• ScanBalt: Baltic Sea region biotech and bioeconomy cluster network. Comparable as a regional cluster organization focused on life sciences in the Baltic / Nordic geography, complementing LithuaniaBIO's regional ambitions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCYP175XiD-_hnG_JhX84Lgw?fbclid=IwAR2nDIf5U3sSmL2pcwae6hASQSyCo1lJxz1azxglfVuG-__GxD2haBp-bCY
• Facebookfacebook.com/LithuaniaBIO
• LinkedInlinkedin.com/company/lithuaniabio

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LithuaniaBIO